OpenDoors, a local emergency shelter, has become the first social services agency in the United States to use GLP-1 medications to treat alcohol use disorder. A woman from Woonsocket credits the grant-funded GLP-1 program with helping her overcome her addiction to alcohol. She describes the treatment as life-changing, emphasizing how it played a crucial role in her recovery. The program represents a novel approach in social services, integrating medical treatment with support for individuals struggling with alcohol abuse. OpenDoors’ initiative highlights the potential of GLP-1 medications, traditionally used for diabetes and weight management, to assist in addiction recovery. This development may pave the way for broader adoption of such treatments in social service settings, offering new hope for those battling alcohol dependence.